Fundz

Fundz Deep Dive

Everything you need to win medac and chiron biotechnology — in one platform.

Who to reach, what to say, and why now on medac and chiron biotechnology — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on medac and chiron biotechnology — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

medac and chiron Partner for the Development of Animal-Free Testing Methods

Nov 07, 2024•over 1 year ago

Contract Type

partnership

Schleswig-HolsteinBiotechnologyPharmaceutical

Description

medac, a global pharmaceutical company, and chiron biotechnology, a Dutch start-up, have announced a promising cooperation for the further development and establishment of animal-free testing methods for the pharmaceutical industry. The partnership aims to test new substances using chiron's advanced organ-on chip technology, which could potentially replace animal testing in drug development.

Company Information

Company

medac and chiron biotechnology

Location

Schleswig-Holstein, Germany

About

medac is a global pharmaceutical company located in Wedel, Germany. chiron biotechnology is a Dutch start-up that has developed an advanced organ-on chip technology.

Predictive Intelligence
Strategic

ML-powered predictions for medac and chiron biotechnology's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.